SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Achillion Pharmaceuticals, Inc. (ACHN)

I received another email in the last 24

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
north40000 Member Profile
Member Level 
Followed By 147
Posts 12,484
Boards Moderated 1
Alias Born 01/19/06
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/16/2017 5:30:15 PM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) "Edgar (US Regulatory)" - 11/16/2017 5:28:33 PM
Achillion Announces Pricing of Secondary Offering Of Common Stock "GlobeNewswire Inc." - 11/15/2017 10:05:00 PM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) "Edgar (US Regulatory)" - 11/14/2017 5:27:29 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/14/2017 5:00:15 PM
Achillion Announces Proposed Secondary Offering of Common Stock "GlobeNewswire Inc." - 11/14/2017 4:03:00 PM
Achillion Reports Preliminary Proof-of-Concept With ACH-4471 for the Treatment of C3G "GlobeNewswire Inc." - 11/14/2017 4:01:00 PM
Achillion Announces ACH-4471 Granted Orphan Drug Designation by the FDA and Positive Opinion for Orphan Drug Designation in t... "GlobeNewswire Inc." - 11/6/2017 6:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/1/2017 4:23:34 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/1/2017 4:14:20 PM
Achillion Reports Third Quarter 2017 Financial Results and Provides Update on Clinical Programs "GlobeNewswire Inc." - 11/1/2017 4:05:00 PM
USPTO Grants Composition of Matter Patent to Achillion for ACH-4471, First-in-Class Small Molecule Complement Alternative Pat... "GlobeNewswire Inc." - 10/24/2017 6:05:00 AM
Achillion Announces Presentation of Data From OMEGA-1 Phase 2b Trial With Odalasvir, AL-335, and Simeprevir (JNJ-4178) at the... "GlobeNewswire Inc." - 10/23/2017 7:00:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 9/28/2017 3:06:35 PM
Achillion to Present at the 2017 Leerink Partners Rare Disease Roundtable Series "GlobeNewswire Inc." - 9/20/2017 6:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 7:37:07 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 7:34:49 AM
Achillion Announces Strengthening of Management Team "GlobeNewswire Inc." - 9/11/2017 3:02:00 AM
Achillion Announces Termination of Worldwide Collaboration for Hepatitis C With Janssen "GlobeNewswire Inc." - 9/11/2017 3:01:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/14/2017 4:58:19 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/8/2017 4:06:39 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/8/2017 4:05:42 PM
Achillion Reports Second Quarter 2017 Financial Results and Proof-of-Concept With a First-in-Class, Oral Factor D Inhibitor "GlobeNewswire Inc." - 8/8/2017 4:01:00 PM
Achillion to Host Second Quarter 2017 Results Conference Call on August 8, 2017 "GlobeNewswire Inc." - 8/1/2017 4:05:00 PM
Achillion Pharmaceutials Announces Key Promotion and Discovery Organization Change "GlobeNewswire Inc." - 7/10/2017 4:05:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist